I might have misunderstood some of it - it's difficult to understand their exact methodology and intentions from the abstract - but, in case it helps anyone, my rudimentary understanding of this study is as follows...
They asked patients to carry out a hand-grip exercise, at 50% of peak capacity, and afterwards they used a blood pressure monitoring cuff to restrict blood flow to and from the arm, for 5 mins. Then they assessed the level of fatigue. Then they did the same with the patients' other arm but without using the cuff after exercise.
They found that the patients experienced more fatigue than the controls who didn't have CFS. And they also found that fatigue in the uncuffed arm was lower than that reported for the cuffed arm.
The aim of this study seems to be to demonstrate that CFS patients have sensitized fatigue and pain pathways to the brain, and have higher levels of fatigue and pain in reaction to normal levels of metabolites. I can't see any information with regards to why the fatigue and pain pathways might be sensitized. The news article seems to be suggesting that their hypothesis is that the neural pathways are sensitized rather than any suggestion of a maladaptive subjective interpretation of normal sensations.
The working hypothesis of the study seems to be rather simplistic and simply intends to demonstrate that metabolites cause fatigue, and by trapping the metabolites in the arm with the cuff, this hypothetical model can be demonstrated because the metabolites continue to exert an effect after the exercise has finished. It's not clear if they actually assessed the levels of metabolites or whether they simply made an assumption about them. They seem to be making rather a lot of assumptions, and the study and conclusions are based on assumptions.
Without measuring the metabolites, I'm at a loss to understand value of the study. All it really tells us is that CFS patients experience increased fatigue after exercise.
I don't understand exactly how they measured fatigue. It says they used self-report measures and quantitative sensory testing (QST), which has been discussed above. I've not read up on the details of QST, but it seems to be a fairly subjective measure, judging from the abstract that
@Snow Leopard has posted above.
The article says: "Researchers focused on the role of muscle metabolites, including lactic acid and adenosine triphosphate, or ATP, in the disease. The study has demonstrated for the first time that these substances, released when a person exercises his or her muscles, seem to activate these neural pathways."
Again, is not clear if they actually measured any of these.
The abstract says: "As no specific metabolic alterations have been identified in CFS patients we hypothesized that sensitized fatigue pathways become activated during exercise corresponding with increased fatigue."
Again, if they didn't measure the metabolites then this is just an assumption; The levels of metabolites could have been higher in the CFS patients then controls.
So the suggestion seems to be that normal levels of metabolites have an abnormal effect in CFS patients because of sensitized neural pathways. But there is no indication that they actually measured the metabolites in this study.
I'm not sure how the cuff was supposed to demonstrate anything in relation to metabolites. Surely the neural pathways are sensitized with or without the cuffs, if the hypothesis holds true? An increase of fatigue after exertion would demonstrate the same issues with or without the cuff.
I can't work out what this refers to, but the news article also says: "“What we have shown now, that has never been shown before in humans, is that muscle metabolites can induce fatigue in healthy people as well as patients who already have fatigue,” said Dr. Roland Staud.."
The abstract concludes: "Our findings provide indirect evidence for significant contributions of peripheral tissues to the increased exercise related fatigue in CFS patients consistent with sensitization of fatigue pathways. Future interventions that reduce sensitization of fatigue pathways in CFS patients may be of therapeutic benefit."
The news article says: "Next, Staud plans to explore treatment interventions and to conduct brain-imaging studies of patients with SEID."
If we are generous to the motives of the investigators, then it seems they are attempting to demonstrate that fatigue originates in the neural pathways and comes about due to faulty neural pathways. i.e. a biomedically based dysfunction of the neural pathways.
The nature of the proposed treatments will be telling. If they intend to trial drugs that have an effect on the neurological pathways then that will tell us a lot about their intentions and motivations, but if they intend to use psychological interventions to supposedly reduce over-sensitive pathways then that also tells us a lot.
Really we need to read the full paper to make sense of it, but I'm not excited by it. It looks like an exceptionally simple study that a school child could design and implement. And, if we ignore all of the assumptions, all it tells us is that fatigued individuals experience more fatigue than non fatigued individuals.